![Dirk Beher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dirk Beher
Algemeen Directeur bij FundaMental Pharma GmbH
Actieve functies van Dirk Beher
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
FundaMental Pharma GmbH
![]() FundaMental Pharma GmbH Pharmaceuticals: MajorHealth Technology FundaMental Pharma GmbH is a neuroscience company based in Heidelberg, Germany. The German company develops first-in-class small inhibitors for the treatment of a range of neurodegenerative diseases. The company's scientists have discovered an entirely new class of drugs that safely counteract glutamate excitotoxicity, a common cause of neurodegeneration. The company's current focus is on amyotrophic lateral sclerosis (ALS) and Huntington's disease, but the applicability of these molecules extends to a range of neurodegenerative disorders such as dementia and aging-related memory loss. FundaMental Pharma was founded in 2016 by Thomas Schulze, Hilmar Bading, and Daniela Mauceri, and Thomas Schulze has been the CEO since 2016. | Directeur/Bestuurslid | 11-04-2024 | - |
Algemeen Directeur | 11-04-2024 | - |
Loopbaan van Dirk Beher
Eerdere bekende functies van Dirk Beher
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Asceneuron SA
![]() Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Directeur/Bestuurslid | 01-10-2012 | 06-10-2023 |
Algemeen Directeur | 01-01-2014 | 06-10-2023 | |
Hoofd Techniek/Wetenschap/O&O | 01-10-2012 | 01-01-2014 | |
Oprichter | 01-10-2012 | 06-10-2023 |
Opleiding van Dirk Beher
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistieken
Internationaal
Duitsland | 3 |
Zwitserland | 2 |
Operationeel
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Asceneuron SA
![]() Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Health Technology |
FundaMental Pharma GmbH
![]() FundaMental Pharma GmbH Pharmaceuticals: MajorHealth Technology FundaMental Pharma GmbH is a neuroscience company based in Heidelberg, Germany. The German company develops first-in-class small inhibitors for the treatment of a range of neurodegenerative diseases. The company's scientists have discovered an entirely new class of drugs that safely counteract glutamate excitotoxicity, a common cause of neurodegeneration. The company's current focus is on amyotrophic lateral sclerosis (ALS) and Huntington's disease, but the applicability of these molecules extends to a range of neurodegenerative disorders such as dementia and aging-related memory loss. FundaMental Pharma was founded in 2016 by Thomas Schulze, Hilmar Bading, and Daniela Mauceri, and Thomas Schulze has been the CEO since 2016. | Health Technology |
- Beurs
- Insiders
- Dirk Beher
- Ervaring